Piezosurgical vs Conventional Exodontia Surgery in Healthy and Patients With Diabetes Mellitus Type 2 (PCSDMT2)

October 30, 2023 updated by: Bozidar Brkovic, DDS, MSc, PhD, Professor, University of Belgrade

Evaluation of Piezosurgical vs Conventional Surgery Approach During Complex Exodontia in Healthy and Patients With Diabetes Mellitus Type 2

This study will evaluateand compare intraoperative and postoperative clinical parameters related to discomfort and wound heeling, as well as laboratory wound healing parameters after piezosurgical and conventional surgery approach during complex exodontia in healthy and patients with Diabetes Mellitus Type 2

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belgrade, Serbia, 11000
        • University of Belgrade Faculty of Dental Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • multiple multi-rooted teeth indicated for extraction
  • controlled DMT2

Exclusion Criteria:

  • HbA1c >7%
  • chronic orofacial pain and infection in orofacial region
  • alcohol and tobacco consumption
  • pregnant women and nursing mothers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy
exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
Experimental: Diabetes mellitus type 2
exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach
exodontia of multi - rooted teeth in upper/lower jaw using piesosurgical approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Duration of osteotomy
Time Frame: from the start of procedure to the end of performing osteotomy
from the start of procedure to the end of performing osteotomy
MicroRNA 21 (Mir-21) expression
Time Frame: during the first 24 hours after intervention
during the first 24 hours after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of tooth sectioning
Time Frame: from the beginning of tooth sectioning to the end of tooth sectioning
from the beginning of tooth sectioning to the end of tooth sectioning
Total exodontia time
Time Frame: from the beginning of surgical procedure to the end of tooth extraction
from the beginning of surgical procedure to the end of tooth extraction
Pain intensity
Time Frame: during the first 24 hours after intervention
Numerical Rating Scale, measuring pain intensity ranging from 0 (no pain) to 10 (the worst pain imaginable)
during the first 24 hours after intervention
Healing Index Score
Time Frame: within 21 days after procedure
3 scoring levels for each of the 4 parameters considered: tissue color (1 = 100% of gingiva pink; 2 = <50% of gingiva red, hyper- emic, movable; 3 = >50% of gingiva red, hyperemic, movable), color and consistency of the healing tissue (1 = close grained, pink; 2 = soft, red; 3 = fragile, greenish or grayish), suppuration (1 = absent; 2 = absent but pronounced amount of plaque around socket walls; 3 = pronounced), and bleeding (1 = absent; 2 = induced by palpation; 3 = spontaneous). Thus, the scoring scale ranged from 4, corresponding to excellent healing, to 12, indicating severely impaired healing.
within 21 days after procedure
First postoperative pain report
Time Frame: within 24 hours after procedure
time between the end of procedure and first pain experienced by the patient measured in minutes
within 24 hours after procedure
First analgesic consumption
Time Frame: within 24 hours after procedure
time from the end of the procedure until first analgesic consumption measured in minutes
within 24 hours after procedure
Clinical appearance of gingival tissue
Time Frame: within 7 days after procedure
clinical appearance of the soft tissues (Visual Analogue Scale 0 to 3, according to the color and presence of edema and bleeding; ie, 0, normally pink, not edematous; 1, pink-red, slightly edematous; 2, red, edematous; and 3, red, edematous, bled easily when touched
within 7 days after procedure
Residual Socket Volume
Time Frame: within 21 days after procedure
the residual socket volume (RSV) is the fraction of the postextraction original cavity still open at each follow-up session (t = 3, 7, 14, and 21 days), computed as the ratio of mesiodistal (MD), bucolingual (BL) and socket depth (SD) at the follow-up session to the baseline value (t=0), measured after extraction (perfect closure corresponds to RSV = 0.00)
within 21 days after procedure
Postextraction wound epithelization
Time Frame: within 21 days after procedure
Epithelialization was measured as bucolingual and mesiodistal diameter of the extraction socket during the follow-up (3, 7, 14 and 21 postoperative day), expressed in millimeters
within 21 days after procedure
Vascular Endothelial Growth Factor (VEGF) level
Time Frame: within 24 hours after intervention
detected by Enzyme-Linked Immunosorbent Essay method
within 24 hours after intervention
Matrix Metalloproteinase 9 (MMP9) level
Time Frame: within 24 hours after intervention
detected by Enzyme-Linked Immunosorbent Essay method
within 24 hours after intervention
Phosphatase and Tensin Homolog (PTEN) level
Time Frame: within 24 hours after intervention
detected by Enzyme-Linked Immunosorbent Essay method
within 24 hours after intervention
Superoxide Dismutase(SOD) enzyme activity (%)
Time Frame: within 24 hours after intervention
Activity level detected by spectrophotometry using SOD Assay kit
within 24 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Milan Vucetic, DDS PHD, University of Belgrade Faculty of Dental Medicine
  • Study Director: Bozidar Brkovic, DDS PhD, University of Belgrade Faculty of Dental Medicine
  • Principal Investigator: Marija S Milic, DDS PhD, University of Belgrade Faculty of Dental Medicine
  • Principal Investigator: Jelena Roganovic, DDS PhD, University of Belgrade Faculty of Dental Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2022

Primary Completion (Actual)

October 10, 2023

Study Completion (Actual)

October 10, 2023

Study Registration Dates

First Submitted

December 2, 2022

First Submitted That Met QC Criteria

September 13, 2023

First Posted (Actual)

September 21, 2023

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 30, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on piesosurgical extraction

3
Subscribe